Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics

Josephine Bourner*, Michel Vaillant, Alex Paddy Abdel Salam, Marie Jaspard, Camille Fritzell, Shevin T Jacob, Tom E Fletcher, Michael Ramharter, Nnennaya Ajayi, Sylvanus Okogbenin, Cyril Erameh, Donald Grant, Robert Samuels, Oladele Oluwafemi Ayodeji, Armand Sprecher, Bronner P Gonçalves, Tansy Edwards, Piero Olliaro, WALC Work Package 2 Working Group

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry